News

FOX 5 Atlanta2m
HIV treatment breakthrough
A major win in the fight against HIV infections. The Food and Drug Administration approved a new twice-a-year shot to prevent ...
Gilead's bi-annual HIV prevention jab gets FDA approval: How much does it cost and how it works? All you need to know…
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...
WAPT7m
Twice-a-year HIV prevention shot Yeztugo could be a game changer for Jackson and beyond
The FDA has approved Yeztugo, the first long-acting injectable PrEP shot, which could significantly impact HIV prevention ...
FDA approves twice-yearly shot to prevent HIV
ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to ...
Zimbabwe Situation1h
Twice-a-year shot to prevent HIV could stop transmission — if people can get it
Men, women, gay, straight – it really just kinds of expands the opportunity for prevention’ Source: Twice-a-year shot to prevent HIV could stop transmission — if people can get it – Zimbabwe News Now ...
Queerty2h
FDA approves world’s first twice-yearly PrEP injection
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
WGAU Radio2h
FDA approves first twice-a-year HIV prevention shot with near-perfect protection
The U.S. Food and Drug Administration has approved a groundbreaking new HIV prevention drug that offers near-total protection ...
FOX 32 Chicago3h
New FDA-approved HIV shot marks major breakthrough
A major win in the fight against HIV. The Food and Drug Administration has approved a new shot that cuts down on the risk of contracting the deadly virus.
Zacks Investment Research on MSN3h
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Dallas Voice4h
FDA approves first twice-a-year PrEP injectable
The U.S. Food and Drug Administration this week approved Gilead Sciences’ twice-a-year shot, lenacapvir, to prevent HIV, Gilead announced on Wednesday, June 18. It is the first and only long-acting ...